PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50124C00010 — DEVELOPMENT OF A NOVEL PRALIDOXIME CHLORIDE AUTO-INJECTOR DEVICE

DEVELOPMENT OF A NOVEL PRALIDOXIME CHLORIDE AUTO-INJECTOR DEVICE is a federal NONE award for Department of Health and Human Services (HHS) held by KALEO, INC.. Estimated value $33.3M ($33.3M obligated). Current period of performance ends Oct 31, 2028. Last award drew 1 bidder.

$33.3M
Estimated Value
$33.3M
Obligated
Oct 31, 2028
PoP End / Expires
1
Bidders (last award)
KALEO, INC.
Incumbent

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

KALEO, INC. holds $33.3M across 3 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Oct 31, 2028 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

NONE
Contract number75A50124C00010
AgencyDepartment of Health and Human Services (HHS)
IncumbentKALEO, INC.
UEILBM4GLJNDK31
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN42
PoP end (current)Oct 31, 2028
Obligated$33.3M

DEVELOPMENT OF A NOVEL PRALIDOXIME CHLORIDE AUTO-INJECTOR DEVICE

Recompete timing

Public
Expiring in 806 days

Current PoP ends Oct 31, 2028 (806 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around May 1, 2027.

Watch this contract — one email →

Incumbent footprint

Public record

KALEO, INC.$33.3M obligated across 3 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$33.3M · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open KALEO, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75A50124C00010?

75A50124C00010 (DEVELOPMENT OF A NOVEL PRALIDOXIME CHLORIDE AUTO-INJECTOR DEVICE) is a Department of Health and Human Services (HHS) award with an estimated value of $33.3M, currently held by KALEO, INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75A50124C00010?

KALEO, INC. is the incumbent with $33.3M across 3 related awards in SCOUT’s public footprint. The current period of performance ends Oct 31, 2028.

When does 75A50124C00010 come up for recompete?

SCOUT tracks a period-of-performance end of Oct 31, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50124C00010